CTKB Cost of Revenue
Cytek Biosciences Inc · Cost of Revenue
CTKB Cost of Revenue
Latest reported$96.68Mperiod ending
CTKB TTM Cost of Revenue ($41.13M → $96.68M)
TTM cost of revenue
High-resolution chart · PNG
CTKB cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 96,679,000 | |
| 98,614,000 | |
| 97,033,000 | |
| 91,601,000 | |
| 89,354,000 | |
| 88,800,000 | |
| 89,347,000 | |
| 90,708,000 | |
| 89,035,000 | |
| 89,385,000 | |
| 83,588,000 | |
| 77,365,000 | |
| 70,158,000 | |
| 64,225,000 | |
| 63,062,000 | |
| 59,358,000 | |
| 58,842,000 | |
| 53,907,000 | |
| 48,806,000 | |
| 44,718,000 | |
| 41,099,000 | |
| 41,302,000 | |
| 41,129,000 |